Nothnick WB

No ORCID on file · 35 papers in corpus
review 2008
Seminars in reproductive medicine ·doi:10.1055/s-0028-1096129

Controlled expression of matrix metalloproteinase-9 (MMP9) is vital for normal uterine physiology, whereas abnormal expression of MMP9 is associated with uterine disease. Despite the importance of MMP9 within the uterus, its regulation is p…

review 2005
Frontiers in Bioscience ·doi:10.2741/1552

The matrix metalloproteinase (MMP) system is composed of the enzymatic component, the MMPs, and the enzyme inhibitory component, the tissue inhibitors of metalloproteinases or TIMPs. It is well established that the MMP system plays a critic…

review 2004
Expert opinion on therapeutic targets ·doi:10.1517/14728222.8.5.459

Endometriosis is an enigmatic, debilitating disease that affects up to 15% of all women of reproductive age. It is characterised by pelvic pain and infertility. Current treatment regimens control the disease by inducing a hypoestrogenic sta…

review 2003
Gynecologic and obstetric investigation ·doi:10.1159/000072073

Endometriosis remains an enigmatic disease in women of reproductive age. Current treatment regimes used to manage the disease are primarily designed to induce a hypoestrogenic state which leads to a reduction in disease and associated sympt…

observational 2001
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/00004347-200104000-00005

Immunohistochemical expression of the standard form of CD44 (CD44s) was examined in archival formalin-fixed endometriotic and matching eutopic endometrial tissue obtained from 25 patients in proliferative (N = 16) and secretory (N = 9) stag…

review 2001
Fertility and sterility ·doi:10.1016/s0015-0282(01)01878-7

OBJECTIVE: To review the literature on the role of autoimmunity in the etiology of endometriosis, compare the similarities in the pathophysiologies between endometriosis and autoimmune diseases, and discuss the use of immunomodulators curre…

other 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00032-6

OBJECTIVE: To evaluate the effects of a gonadotropin-releasing hormone agonist (GnRH-a) on plasminogen activator (PA), matrix metalloproteinase (MMP), plasminogen activator inhibitor (PAI) and matrix metalloproteinase inhibitor (MMPI) activ…

lab-animal 1998
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.1600-0897.1998.tb00067.x

PROBLEM: Elevated levels of activated macrophages are associated with endometriosis, but their role in the etiology of the disease is uncertain. The current study was undertaken to examine whether activated macrophages could modulate perito…

other 1994
Fertility and sterility ·doi:10.1016/s0015-0282(16)56519-4

OBJECTIVE: To test the hypothesis that endometriotic tissue secretes endometriotic-specific proteins into the peritoneal fluid (PF) of women with endometriosis. DESIGN: A prospective design was utilized in this study. SETTING: Tertiary ca…

lab-animal 1994
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.1600-0897.1994.tb00860.x

PROBLEM: The immune system has been implicated in the pathophysiology of endometriosis. To determine if modulation of the immune system influences endometriotic implant growth and protein production, the following experiment was conducted. …